Immutep Limited
- IMMP
- NASDAQ
- Biotechnology
- LAG-3 Immunotherapy
- Cancer/Autoimmune Biotech
$3.20
Today −0.31%Quote Oct 16, 2026, 08:00 PM UTC
−49.53%over the last month
Max drawdown −49.5%From 1-month high −49.5%3 months −60.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$23.6M
Quote Oct 16
Next earnings
Feb 25
Expected, not confirmed
Analyst target
$4.25
+32.8% from here
Floor
$3.09
3.4% below price
Where the price sits
4 analysts
Analyst range, low to high
$3.50$5.00
- Price $3.20
- Resistance $3.28
- Consensus $4.25
The price is right under resistance. Analysts' average target sits about 33% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IMMPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
53
Founded
1987